Matrixx Initiatives, owner of the over-the-counter Zicam brand, has been recapitalized. Prospect Capital provided $80 million of floating-rate first-lien senior-secured loans and a senior-secured revolving credit facility to support the recapitalization. Zicam develops and markets cold remedy products for the OTC market. H.I.G. Capital owns a controlling interest in its parent company.